SI2196545T1 - Postopki za napovedovanje odziva pacientov z multiplo sklerozo na terapijo z interferonom in diagnosticiranje multiple skleroze - Google Patents
Postopki za napovedovanje odziva pacientov z multiplo sklerozo na terapijo z interferonom in diagnosticiranje multiple sklerozeInfo
- Publication number
- SI2196545T1 SI2196545T1 SI200730969T SI200730969T SI2196545T1 SI 2196545 T1 SI2196545 T1 SI 2196545T1 SI 200730969 T SI200730969 T SI 200730969T SI 200730969 T SI200730969 T SI 200730969T SI 2196545 T1 SI2196545 T1 SI 2196545T1
- Authority
- SI
- Slovenia
- Prior art keywords
- multiple sclerosis
- predicting
- response
- methods
- diagnosing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06003978A EP1826277A1 (en) | 2006-02-27 | 2006-02-27 | Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis |
| EP10003542A EP2196545B1 (en) | 2006-02-27 | 2007-02-27 | Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2196545T1 true SI2196545T1 (sl) | 2012-09-28 |
Family
ID=36658688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200730969T SI2196545T1 (sl) | 2006-02-27 | 2007-02-27 | Postopki za napovedovanje odziva pacientov z multiplo sklerozo na terapijo z interferonom in diagnosticiranje multiple skleroze |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8071299B2 (sl) |
| EP (4) | EP1826277A1 (sl) |
| AT (2) | ATE466959T1 (sl) |
| DE (1) | DE602007006284D1 (sl) |
| DK (2) | DK1991696T3 (sl) |
| SI (1) | SI2196545T1 (sl) |
| WO (1) | WO2007096197A2 (sl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009060066A1 (en) * | 2007-11-09 | 2009-05-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A method for predicting the therapeutic responsiveness of patients to a medical treatment with an interferon |
| CA2724420A1 (en) * | 2008-07-24 | 2010-01-28 | Merck Serono S.A. | Use of genetic markers for identifying the response to interferon treatment in multiple sclerosis patients |
| WO2011117267A1 (en) * | 2010-03-24 | 2011-09-29 | Merck Serono Sa | Cladribine treatment of multiple sclerosis in patient groups defined by genotype |
| EP2380992A1 (en) * | 2010-04-21 | 2011-10-26 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Methods for predicting an antibody response to interfer on therapy in multiple sclerosis patients |
| CN110494880A (zh) * | 2017-01-27 | 2019-11-22 | 欧瑞3恩公司 | 基于个人基因轮廓来判定和展现购买建议的系统和方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1114998A3 (en) | 1999-10-28 | 2001-08-22 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for determining the success rate of treatment of multiple sclerosis |
| AU2002337671A1 (en) | 2001-08-07 | 2003-02-24 | Genaissance Pharmaceuticals, Inc | Polymorphisms associated with multiple sclerosis |
| SE0103423D0 (sv) | 2001-10-12 | 2001-10-12 | Astrazeneca Ab | Polymorphism |
| GB0307914D0 (en) | 2003-04-07 | 2003-05-14 | Univ Dundee | Cytochrome p450 |
| CA2549913A1 (en) * | 2003-11-26 | 2005-06-16 | The Ohio State University Research Foundation | Polymorphic cd24 genotypes that are predictive of multiple sclerosis risk and progression |
-
2006
- 2006-02-27 EP EP06003978A patent/EP1826277A1/en not_active Withdrawn
-
2007
- 2007-02-27 DK DK07711702.6T patent/DK1991696T3/da active
- 2007-02-27 SI SI200730969T patent/SI2196545T1/sl unknown
- 2007-02-27 EP EP07711702A patent/EP1991696B1/en not_active Not-in-force
- 2007-02-27 EP EP10003543A patent/EP2196546B1/en not_active Not-in-force
- 2007-02-27 AT AT07711702T patent/ATE466959T1/de not_active IP Right Cessation
- 2007-02-27 DK DK10003542.7T patent/DK2196545T3/da active
- 2007-02-27 US US12/280,665 patent/US8071299B2/en not_active Expired - Fee Related
- 2007-02-27 DE DE602007006284T patent/DE602007006284D1/de active Active
- 2007-02-27 WO PCT/EP2007/001689 patent/WO2007096197A2/en active Application Filing
- 2007-02-27 EP EP10003542A patent/EP2196545B1/en not_active Not-in-force
- 2007-02-27 AT AT10003542T patent/ATE557102T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2196545A1 (en) | 2010-06-16 |
| US20090186773A1 (en) | 2009-07-23 |
| DK1991696T3 (da) | 2010-08-30 |
| ATE557102T1 (de) | 2012-05-15 |
| EP2196545B1 (en) | 2012-05-09 |
| WO2007096197A3 (en) | 2007-10-18 |
| US8071299B2 (en) | 2011-12-06 |
| EP1991696B1 (en) | 2010-05-05 |
| ATE466959T1 (de) | 2010-05-15 |
| WO2007096197A2 (en) | 2007-08-30 |
| DE602007006284D1 (de) | 2010-06-17 |
| EP2196546A1 (en) | 2010-06-16 |
| EP1991696A2 (en) | 2008-11-19 |
| DK2196545T3 (da) | 2012-07-16 |
| EP2196546B1 (en) | 2013-02-27 |
| EP1826277A1 (en) | 2007-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007103415A3 (en) | System and method for providing therapeutic treatment using a combination of ultrasound, electro-stimulation and vibrational stimulation | |
| TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
| WO2007033216A3 (en) | Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state | |
| EP1958648A4 (en) | THERAPEUTIC PROCESS FOR BLOOD CLEANING DISORDER | |
| GB0418542D0 (en) | Integrated biosensor and simulation system for diagnosis and therapy | |
| WO2007087468A3 (en) | Adiponectin for treatment of various disorders | |
| HK1095762A1 (en) | Ctgf as target for the therapy of microalbuminuriain patients with diabetic nephropathy | |
| ZA200703601B (en) | Medicaments for the treatment or prevention of fibriotic diseases | |
| HK1070575A1 (en) | Use of botulinum toxin for treating cardiovasculardiseases | |
| IL191233A (en) | Computer-Aided Method for Predicting Clinical Effects of Dosage Drugs Proposed to Treat Recognized Brain Disease | |
| MX2007005649A (es) | Carboxiamidas de azaindol. | |
| IL182906A0 (en) | Method for treatment of movement disorders | |
| GB0707186D0 (en) | Respiration monitoring apparatus,respireation monitoring system,medical treatment system,respiration monitoring method,respiration monitoring program | |
| MX2010002498A (es) | Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol. | |
| SG152233A1 (en) | Benzoxazine for treating respiratory tract diseases | |
| HK1089380A1 (en) | Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones | |
| SI2196545T1 (sl) | Postopki za napovedovanje odziva pacientov z multiplo sklerozo na terapijo z interferonom in diagnosticiranje multiple skleroze | |
| EP1863940A4 (en) | METHOD OF RISK MANAGEMENT FOR NATALIZUMAB TREATED PATIENTS | |
| WO2007023154A3 (de) | EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG | |
| HK1119592A1 (en) | Interferon lambda therapy for treatment of respiratory diseases | |
| EP1922689A4 (en) | METHOD AND SYSTEM FOR CONTROLLING A THERAPEUTIC PROCEDURE | |
| WO2004030618A3 (en) | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines | |
| IL164009A0 (en) | Device for treating patients by means of brain stimulation | |
| EP1843781A4 (en) | COMPOSITION FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF INFLAMMATORY CHRONIC DISEASES OF AIRWAYS | |
| SG148186A1 (en) | Methods and reagents for the treatment of inflammatory disorders |